142 related articles for article (PubMed ID: 21473129)
21. Remacemide.
Muir KT; Palmer GC
Epilepsy Res Suppl; 1991; 3():147-52. PubMed ID: 1777071
[No Abstract] [Full Text] [Related]
22. Induction of epileptic negative myoclonus by addition of lacosamide to carbamazepine.
Belcastro V; Arnaboldi M; Taborelli A; Prontera P
Epilepsy Behav; 2011 Mar; 20(3):589-90. PubMed ID: 21367668
[No Abstract] [Full Text] [Related]
23. Significant Improvements of EEG and Clinical Findings With Oral Lacosamide in a Patient With Ring Chromosome 20.
Onder H; Tezer FI
Clin EEG Neurosci; 2016 Oct; 47(4):330-332. PubMed ID: 26240087
[No Abstract] [Full Text] [Related]
24. [Lacosamide, new antiepileptic with broad perspectives].
Gutiérrez-Álvarez AM; Sagarra-Mur D; Jiménez-Corral C
Neurologia; 2011 Nov; 26(9):568-9. PubMed ID: 21565431
[No Abstract] [Full Text] [Related]
25. Lacosamide-induced second-degree atrioventricular block in a patient with partial epilepsy.
Nizam A; Mylavarapu K; Thomas D; Briskin K; Wu B; Saluja D; Wong S
Epilepsia; 2011 Oct; 52(10):e153-5. PubMed ID: 21801173
[TBL] [Abstract][Full Text] [Related]
26. Sinus node dysfunction: an adverse effect of lacosamide.
Chinnasami S; Rathore C; Duncan JS
Epilepsia; 2013 Jun; 54(6):e90-3. PubMed ID: 23360388
[TBL] [Abstract][Full Text] [Related]
27. Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial.
Shaibani A; Biton V; Rauck R; Koch B; Simpson J
Eur J Pain; 2009 May; 13(5):458-63. PubMed ID: 18619874
[TBL] [Abstract][Full Text] [Related]
28. Lacosamide: new adjunctive treatment option for partial-onset seizures.
Chung SS
Expert Opin Pharmacother; 2010 Jun; 11(9):1595-602. PubMed ID: 20482307
[TBL] [Abstract][Full Text] [Related]
29. The adjuvant treatment of partial seizures in epilepsy: focus on lacosamide. Foreword.
Ben-Menachem E
CNS Drugs; 2011 Dec; 25 Suppl 1():1-2. PubMed ID: 22141346
[No Abstract] [Full Text] [Related]
30. Single-dose oral lacosamide in refractory simple partial status epilepticus: case report and review.
Hawkes MA; Fernández Suárez M; Ugarnes G; D'Giano C
Clin Neuropharmacol; 2013; 36(4):138-40. PubMed ID: 23860347
[TBL] [Abstract][Full Text] [Related]
31. Lacosamide, a newer antiepileptic.
Patyar S; Medhi B
Neurosciences (Riyadh); 2010 Jan; 15(1):3-6. PubMed ID: 20677583
[TBL] [Abstract][Full Text] [Related]
32. The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy.
Wesnes KA; Edgar C; Dean AD; Wroe SJ
Epilepsy Behav; 2009 Mar; 14(3):522-8. PubMed ID: 19111629
[TBL] [Abstract][Full Text] [Related]
33. Drugs for epilepsy.
Treat Guidel Med Lett; 2013 Feb; 11(126):9-18. PubMed ID: 23348233
[No Abstract] [Full Text] [Related]
34. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T;
Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227
[TBL] [Abstract][Full Text] [Related]
35. Initial post marketing experience with lacosamide in adult patients with epilepsy.
Harden CL; Cohn A; Lowe M; Serrano E
Epilepsy Res; 2012 Feb; 98(2-3):260-3. PubMed ID: 22015002
[TBL] [Abstract][Full Text] [Related]
36. Perampanel (Fycompa) for epilepsy.
Med Lett Drugs Ther; 2014 Feb; 56(1435):9-10. PubMed ID: 24662975
[No Abstract] [Full Text] [Related]
37. [Efficacy of lacosamide in the treatment of neuropathic pain].
Bermejo PE; Alba-Alcantara L
Rev Neurol; 2013 Feb; 56(3):188-90. PubMed ID: 23359081
[No Abstract] [Full Text] [Related]
38. Six months of postmarketing experience with adjunctive lacosamide in patients with pharmacoresistant focal epilepsy at a tertiary epilepsy center in Germany.
Wehner T; Bauer S; Hamer HM; Hattemer K; Immisch I; Knake S; Nowak M; Reif PS; Strzelczyk A; Rosenow F
Epilepsy Behav; 2009 Nov; 16(3):423-5. PubMed ID: 19767242
[TBL] [Abstract][Full Text] [Related]
39. Lacosamide as treatment of epileptic seizures - cost utility results for Sweden.
Bolin K; Berggren F; Forsgren L
Acta Neurol Scand; 2010 Jun; 121(6):406-12. PubMed ID: 20199516
[TBL] [Abstract][Full Text] [Related]
40. A Well-Tolerated and Effective Antiepileptic Drug for Patients With Myasthenia Gravis at Last?
Sánchez-Villalobos JM; Villegas-Martínez I; Pérez-Vicente JA
Clin Neuropharmacol; 2018; 41(2):80-81. PubMed ID: 29432285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
